Quarterly report · Q2
4350.TEDINET S100PGSX
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥106.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥502m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥512m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥64.1bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥62.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥62.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥50.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥49.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥913m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥902m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥832m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥16.64 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.62 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.35 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.46 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.09 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 21.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥151m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥151m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥10m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥412m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥412m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.2bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥50.8bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥50.8bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7m |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥404m |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥65m |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥33m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥53.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥53.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥412m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.3bn |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥152m |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥152m |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥12m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥350m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥350m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥1.0bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥49.7bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥49.7bn |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q2r_E05274-000Community Pharmacy Network Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥350m |
| jpcrp040300-q2r_E05274-000Leasing And Facility Related Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥32m |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05274-000Meal Catering Segmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥52.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥52.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥350m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 198000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 175000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -4000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -3000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 95000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 138000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -112000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YTDDuration | 9000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYTDDuration | -7000000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YTDDuration | 5000000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 47000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -7000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -437000000 | JPY |
| Decrease increase in account receivable ope cf | Prior1YTDDuration | 16000000 | JPY |
| Decrease increase in account receivable ope cf | CurrentYTDDuration | -26000000 | JPY |
| Decrease increase in account receivable medical income ope cf | Prior1YTDDuration | 24000000 | JPY |
| Decrease increase in account receivable medical income ope cf | CurrentYTDDuration | 11000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -531000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -456000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 1000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 150000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 45000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -98000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -322000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 205000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 2893000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 2410000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 4000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 2000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -94000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -138000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -1889000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -572000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 913000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 1701000000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -0 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -0 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -927000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -670000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 19000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 22000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -112000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -156000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 379000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | -209000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from transfer of business inv cf | Prior1YTDDuration | 11000000 | JPY |
| Proceeds from transfer of business inv cf | CurrentYTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |